A new form of nasal drug administration for pain medications could improve response time by directly affecting the central nervous system, according to a Anesthesia & Analgesia report.
The Latest
Researchers have mapped hydrogenotrophic microbes in the colon to help gastroenterologists and other clinicians better understand their density and locations, according to an International Society for Microbial Ecology Journal abstract.
Morphine and other strong pain medications may be directed to the central nervous system through a new approach to nasal drug administration, according to a study published in the Sept. 2011 issue of Anesthesia & Analgesia.
A study published in the Journal of the American Medical Association suggests discharged patients from hospital ICUs are at greater risk of unintentional discontinuation of prescription medications than all discharged patients. Read the full report in Becker’s Hospital Review on…
Joseph Kubacki, MD, former ophthalmology chair at Temple University School of Medicine in Philadelphia, has been convicted of charging for $3 million in claims for care done by medical residents, according to an Associated Press report.
Pennsylvania physicians Lawrence Wean, MD, and John Kotyo, MD, were found guilty of negligence in the care of a patient who later died of sepsis, according to a Delco Times report.
Anesthesia Business Consultants is encouraging anesthesiologists, nurse anesthetists and anesthesiologist assistants who last validated their Medicare enrollment before March 25, 2011, to revalidate by March 23, 2013.
People who regularly use certain applications on a mobile device are three times more likely to go online at least once a day for medical information than other Internet users, according to a Health Tech report.
A Beckman Coulter facility in Brea, Calif., has been issued an FDA warning letter for failing to follow required procedures in making design changes of its photometer boards, according to the warning letter.
California should be able to regulate health insurance premiums by giving the Department of Insurance the authority to modify or reject proposed increases, according to an L.A. Times editorial report.